Skip to main content

Table 6 Comparison of the haplotype frequencies between the healthy subjects and the HIV/AIDS patients

From: PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients

Haplotypes

Healthy subjects n (freq)

HIV/AIDS patients n (freq)

Efavirenz levels (μg/mL)*

Global p-value#

NR1I2 haplotypes [rs2472677-rs3732356-rs6785049]

C-T-A

7 (0.025)

6 (0.012)

2.13

 

C-T-G

109 (0.367)

190 (0.379)

4.00

 

C-G-G

64 (0.216)

114 (0.226)

6.69

0.015

T-T-A

16 (0.052)

6 (0.011)

4.94

 

T-T-G

96 (0.321)

172 (0.343)

4.23

 

T-G-G

6 (0.019)

13 (0.026)

4.55

 

NR1I3 haplotypes [rs2307424-rs2502815-rs3003596]

C-C-T

153 (0.489)

310 (0.530)

4.97

 

C-C-C

58 (0.187)

122 (0.208)

3.45

 

C-T-T

7 (0.023)

8 (0.013)

3.53

0.424

C-T-C

75 (0.240)

121 (0.207)

3.87

 

T-C-T

14 (0.045)

22 (0.037)

4.42

 

T-C-C

4 (0.012)

3 (0.005)

1.89

 
  1. *Efavirenz levels are for the HIV/AIDS patients only; #Global p-value is for comparison of haplotype frequencies between healthy subjects and HIV/AIDS patients.